Beryl Drugs Other Announcement
Beryl Drugs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
ALFA Filings
Every announcement, straight from the exchange
Every Beryl Drugs other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Beryl Drugs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Beryl Drugs Limited has submitted its quarterly compliance certificates regarding Regulation 74(5) and a non-applicability confirmation for Regulation 57(5) for the quarter ended September 30, 2026.
Beryl Drugs Ltd submitted a certificate claiming exemption from Corporate Governance provisions under Regulation 15(2) of SEBI LODR for the year ended March 31, 2026. The company qualifies for the exemption as its paid-up capital (₹5.07 Crore) and net worth (₹9.50 Crore) remain below the prescribed regulatory thresholds.
Beryl Drugs Ltd has submitted its quarterly compliance reports for the period ended March 31, 2026. The filing includes certificates regarding dematerialisation of securities and maintenance of share transfer facilities. These are routine regulatory submissions ensuring administrative and operational transparency for shareholders.
Beryl Drugs Ltd submitted compliance certificates for the quarter and year ended March 31, 2026. The filings confirm maintenance of share transfer facilities by Adroit Corporate Services and compliance with SEBI depository and non-applicability regulations.